Sun Pharmaceutical Industries Limited — Updates, 25-10-2024: Press Release

Sun Pharmaceutical Industries Limited announces positive clinical findings for its acne treatment, WINLEVI® (clascoterone) Cream 1%. Recent studies indicate significant reductions in facial sebum levels and acne severity, especially among patients with skin of color. WINLEVI is effective when used alongside other topical medications, demonstrating stability in combination therapies. This versatility positions WINLEVI as a promising option for acne treatment in patients aged 12 and older, showing good tolerability and minimal adverse reactions.